NYAM Section on Dermatology Presents the 2012 Howard Fox, MD Memorial Lecture
Date: March 13, 2012 to March 13, 2012
Time: 6:00 PM - 8:00 PM p.m., Lecture 7:00 p.m. – 8:00 p.m.
Speaker(s): Torello Lotti, MD, Professor of the Dermatology and Venereology Division at Guglielmo Marconi University, Rome, Italy - Honorary Professor of Dermatology - China Medical University Shenyang, 18 Dec.2011
Chair, Executive Scientific Committee Vitiligo Research Foundation, New York , NY , USA.
Sponsored by: NYAM Section on Dermatology
Location: The New York Academy of Medicine, 1216 Fifth Avenue at 103rd Street, New York, NY 10029
"Vitiligo: What's New – Update in 2012"
Vitiligo is a chronic acquired hypomelanotic disorder affecting 0.5-2% of the world's population. Different forms of vitiligo have been described, according to the distribution and the extent of the achromic lesion. Several hypotheses have been proposed to explain the pathogenesis of vitiligo. The two major pathogenetic hypotheses are focused on immune-mediated or toxic-mediated cell damage primarily directed at melanocytes. New data demonstrated an important involvement of the keratinocytes and dendritic cells in the pathogenesis of vitiligo.
According to our progress in understanding Vitiligo pathogenesis, new and experimental therapies, such as narrow-band ultraviolet B microphototherapy (NB-UVB), narrow-band ultraviolet B excimer laser and monochromatic excimer light are available for the treatment of the disease. In addition, there are new topical treatments such as antioxidants, tacrolimus and pimecrolimus, prostaglandin E, and vitamin D derivatives. Excellent therapeutic results can be achieved through combination treatments.
About the Speaker(s)
Torello Lotti, MD, Prof. Lotti is Professor of the Dermatology and Venereology Division at Guglielmo Marconi University, Rome, Italy. Previously, he was Professor of the Dermatology and Venereology Division at University of Florence School of Medicine, Florence, Italy.
The fields of his principal scientific investigations are focused on the study of neuropeptides in numerous skin diseases, of plasminogen activators in autoimmune dermatoses and in lichen planus, and the clinical aspects and treatment of psoriasis vulgaris with particular emphasis on new therapies with biological agents. Of particular relevance is his research on the pathogenesis and innovative treatments for vitiligo.
Dr. Lotti is Visiting Professor and Director, International Centre for Balneology, Cell Biology, and Physiotherapy, Thomas Jefferson University, Philadelphia (PA, USA), Visiting Professor of Dermatology in six international universities, and Key Note Lecturer, Japanese Society of Cosmetic Dermatology. Past activities: Past-President of the Italian Society of Dermatology and Venereology, Past President of International Society of Dermatology.